0001209191-23-047104.txt : 20230823 0001209191-23-047104.hdr.sgml : 20230823 20230823175901 ACCESSION NUMBER: 0001209191-23-047104 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230821 FILED AS OF DATE: 20230823 DATE AS OF CHANGE: 20230823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harford Simon N.R. CENTRAL INDEX KEY: 0001443705 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33497 FILM NUMBER: 231198501 MAIL ADDRESS: STREET 1: AVON PRODUCTS, INC. STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001178879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200422823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: (215) 921-7600 MAIL ADDRESS: STREET 1: 3675 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 FORMER COMPANY: FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC DATE OF NAME CHANGE: 20020729 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-21 0 0001178879 AMICUS THERAPEUTICS, INC. FOLD 0001443705 Harford Simon N.R. C/O AMICUS THERAPEUTICS, INC. 3675 MARKET STREET PHILADELPHIA PA 19104 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-08-21 4 A 0 106973 0.00 A 106973 D Stock Options (right to buy) 12.62 2023-08-21 4 A 0 189043 0.00 A 2033-08-21 Common Stock 189043 189043 D Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on August 21, 2024 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock. These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter. /s/ Christian Formica, Attorney-in-Fact 2023-08-23